A possible hypothesis to justify this difference between the groups would be that the group with low PTH levels may have greater variation in calcium levels due to oral supplementation; therefore, transient hypercalcemia may increase the calcium–phosphorus product and promote vascular calcification (7). The gene discussed is PTH; the disease is Hypercalcemia.